Atlas Trials

Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT01685125 · UNKNOWN

Trial details

NCT number
NCT01685125
Sponsor
University of Southern California
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
Start date
2012-09-01
Primary completion
2016-03-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.